Semaglutide Weight Management and Cardiovascular Risk Reduction

Insulin: Key take-aways Despite many new treatment options, many patients eventually need insulin treatment The burden of treatment and daily injections can be a barrier for good glycaemic control Insulin icodec appears to have a superior efficacy profile with added weekly convenience and a low rate of hypoglycemia* Overall, insulin icodec has the potential to be an ideal starter insulin for people with T2D *Less than one event per year for level 2 or 3 hypoglycemia in the insulin naïve and in the basal switch T2D population T2D: Type 2 Diabetes C O O O novo nordisk

View entire presentation